首页> 外文期刊>American Journal of Clinical Oncology: Cancer Clinical Trials >Clinical Utility of a Blood-based Protein Assay on Diagnostic Colonoscopy Referrals for Elevated-risk Colorectal Cancer Patients in Primary Care
【24h】

Clinical Utility of a Blood-based Protein Assay on Diagnostic Colonoscopy Referrals for Elevated-risk Colorectal Cancer Patients in Primary Care

机译:血基蛋白质测定对初级护理升高风险结直肠癌患者诊断结肠镜检查的临床用途

获取原文
获取原文并翻译 | 示例
       

摘要

Background: Colonoscopies are effective in finding early stage colorectal cancer (CRC), which when found in a timely manner, dramatically improve survival rates. A significant number of at-risk patients are still not screened. We investigated the utility of a blood-based protein assay to assess for CRC in patients with elevated risk on the quality of preventive care delivered by board-certified primary care physicians (PCPs) in the United States.
机译:背景:结肠镜检查在寻找早期结直肠癌(CRC)方面是有效的,当时以及时发现,显着提高存活率。 大量的风险患者仍未筛选。 我们调查了血液型蛋白质测定的效用,以评估在美国董事会认证的初级保健医生(PCP)在美国提供的预防性护理质量风险升高的患者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号